MCA MCA-F-501MCA-F-501/15, version 1 – 24 February 2025
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
MCA-F-501/15, version 1 – 24 February 2025 is the official MCA identifier for “Notification of the End of a Clinical Trial”. MCA-F-501/15, version 1 – 24 February 2025 is the official identifier MCA uses for this instrument.
- Instrument
- MCA-F-501
- Full name
- MCA-F-501/15, version 1 – 24 February 2025
- Category
- Clinical Trials
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Notification of the End of a Clinical Trial
Complete two-page end-of-clinical-trial notification, version 1 dated 24 February 2025. It distinguishes the end in The Gambia, the global end and early termination, and requests two submissions if national and global end dates differ. Its reference to applicable clinical summary-report deadlines supplies no numerical general device-market deadline. The second-page Clinical Trial Progress Report header is preserved as printed. Later revisions and current applicability remain unverified.
MCA-F-501/15, version 1 – 24 February 2025 is the official identifier MCA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.